WASHINGTON, June 17- The U.S. Supreme Court ruled on Monday that the Federal Trade Commission can challenge deals brand-name drug companies make with generic rivals that keep cheaper products off the market.
WASHINGTON, June 17- The U.S. Supreme Court on Monday agreed to consider whether a New Jersey township's plan to redevelop lower income housing violated the Fair Housing Act because it would reduce affordability for minorities.
WASHINGTON, June 17- The U.S. Supreme Court on Monday agreed to consider whether a New Jersey township's plan to redevelop lower income housing violated the Fair Housing Act because it would reduce affordability for minorities.
WASHINGTON, June 17- The U.S. Supreme Court on Monday agreed to consider whether a New Jersey township's plan to redevelop lower income housing violated the Fair Housing Act because it would negatively impact minorities.
NEW YORK, June 13- The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech industry, but experts said it isn't: the industry has already moved on.
*Myriad Genetics shares rise after ruling, then fall. WASHINGTON, June 13- A unanimous U.S. Supreme Court on Thursday prohibited patents on naturally occurring human genes but allowed legal protections on synthetically produced genetic material in a compromise ruling hailed as a partial victory for patients and the biotechnology industry.
*Myriad Genetics shares up more than 10 percent after ruling. WASHINGTON, June 13- In a first of its kind ruling on human genes, a unanimous U.S. Supreme Court on Thursday decided that synthetically produced genetic material can be patented but naturally occurring DNA extracted from the human body cannot.
WASHINGTON, June 13- The U.S. Supreme Court on Thursday ruled partially for Myriad Genetics Inc on the closely watched issue of whether human genes can be patented, deciding synthetically produced genetic material can be patented but naturally occurring DNA cannot. Myriad's shares jumped more than 8 percent to $36.83 after the ruling was issued.
WASHINGTON, June 13- The U.S. Supreme Court on Thursday issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc over the closely watched issue of whether human genes can be patented.
WASHINGTON, June 10- The U.S. Supreme Court agreed on Monday to hear British company BG Group Plc's appeal over a $185.3 million arbitration award it won against Argentina that an appeals court later threw out.
WASHINGTON, June 10- The U.S. Supreme Court on Monday agreed to hear British company BG Group Plc's appeal over a $185.3 million arbitration award it won against Argentina that an appeals court later threw out.
No reason has been given yet for the departure of founder and executive chairman George Zimmer, reports CNBC's Courtney Reagan. Zimmer has long been the face of the company.
Wednesday, 19 Jun 2013 | 10:52 AM ETCNBC's Rick Santelli, explains why he hears 'crickets" when he asks questions about Fed Chairman Bernanke's policies. "Enough is enough," he rants.
Wednesday, 19 Jun 2013 | 11:36 AM ETAre reporters lobbing "softball" questions at the Fed chairman? CNBC's Rick Santelli and the Wall Street Journal's Jon Hilsenrath, debate whether the economy continues to need quantitative easing. I'm trying to inform the public about what the Fed is up to, says Hilsenrath.